Lucie Yang, D. Rieves, C. Ganley
Aug 29, 2012
Citations
4
Influential Citations
173
Citations
Quality indicators
Journal
The New England journal of medicine
Abstract
The FDA has approved a new radiopharmaceutical agent to assist in detecting causes of cognitive impairment other than Alzheimer's disease. But unique features of imaging information obtained with florbetapir F18 injection require careful consideration in diagnosis.